KASL临床实践指南：丙型肝炎的管理 - Suppr

Suppr

超能文献

KASL clinical practice guidelines: management of hepatitis C.

出版信息

Clin Mol Hepatol. 2014 Jun;20(2):89-136. doi: 10.3350/cmh.2014.20.2.89. Epub 2014 Jun 30.

DOI:10.3350/cmh.2014.20.2.89

PMID:25032178

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4099340/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39fa/4099340/95f5a4d905b9/cmh-20-89-g001.jpg

相似文献

KASL clinical practice guidelines: management of hepatitis C.

Clin Mol Hepatol. 2014 Jun;20(2):89-136. doi: 10.3350/cmh.2014.20.2.89. Epub 2014 Jun 30.

KASL clinical practice guidelines: management of hepatitis C.

Clin Mol Hepatol. 2016 Mar;22(1):76-139. doi: 10.3350/cmh.2016.22.1.76. Epub 2016 Mar 28.

Diagnostic challenges of hepatitis C.

JAMA. 2014 Jun 25;311(24):2536-7. doi: 10.1001/jama.2014.306.

[Therapeutic response to alpha-interferon in chronic alcoholics with viral hepatitis C].

Klin Med (Mosk). 1998;76(8):33-5.

Recovery from chronic hepatitis C in long-term responders to ribavirin plus interferon alfa.

Lancet. 2000 Jul 1;356(9223):41. doi: 10.1016/S0140-6736(00)02434-X.

Clinical decisions. Management of incidental hepatitis C virus infection.

N Engl J Med. 2009 Apr 30;360(18):1902-6. doi: 10.1056/NEJMclde0900131.

[Interferon therapy for acute hepatitis C: evaluation by HCV antibody, HCV genotypes and serum RNA titer].

Nihon Rinsho. 1995 Sep;53 Suppl(Pt 1):521-7.

[Renewed 2015 Clinical Practice Guidelines for Management of Hepatitis C by Korean Association for the Study of the Liver; What Has Been Changed? - Treatment of Chronic Hepatitis C Genotype 2 and 3].

Korean J Gastroenterol. 2016 Mar;67(3):132-6. doi: 10.4166/kjg.2016.67.3.132.

Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serum.

J Hepatol. 1996 Dec;25(6):827-32. doi: 10.1016/s0168-8278(96)80285-6.

[The diagnosis of hepatitis C virus infection].

Orv Hetil. 2014 Jun 29;155(26):1019-23. doi: 10.1556/OH.2014.29972.

引用本文的文献

Prior antiviral treatment and mortality among patients with hepatitis C virus-related hepatocellular carcinoma: A national cohort study.

PLoS One. 2021 Aug 3;16(8):e0255624. doi: 10.1371/journal.pone.0255624. eCollection 2021.

Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases.

Intest Res. 2020 Jan;18(1):18-33. doi: 10.5217/ir.2019.09155. Epub 2020 Jan 30.

Effects of vitamin D supplements in patients with chronic hepatitis C: a randomized, multi-center, open label study.

Korean J Intern Med. 2020 Sep;35(5):1074-1083. doi: 10.3904/kjim.2018.273. Epub 2019 Nov 12.

Impact of Interferon-Based Treatment on Quality of Life and Work-Related Productivity of Korean Patients with Chronic Hepatitis C.

Gut Liver. 2020 May 15;14(3):368-376. doi: 10.5009/gnl18100.

Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL.

Clin Mol Hepatol. 2018 Sep;24(3):278-293. doi: 10.3350/cmh.2018.1002. Epub 2018 May 2.

Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety.

Gut Liver. 2018 May 15;12(3):324-330. doi: 10.5009/gnl17298.

Real-life prevalence of resistance-associated variants against non-structural protein 5A inhibitors and efficiency of Daclatasvir + Asunaprevir therapy in Korean patients with genotype 1b hepatitis C.

Virol J. 2017 Aug 24;14(1):164. doi: 10.1186/s12985-017-0826-1.

Clinical features of hepatitis B and C virus infections, with high α-fetoprotein levels but not hepatocellular carcinoma.

Medicine (Baltimore). 2017 Jan;96(2):e5844. doi: 10.1097/MD.0000000000005844.

Estimating the Cost-Effectiveness of One-Time Screening and Treatment for Hepatitis C in Korea.

PLoS One. 2017 Jan 6;12(1):e0167770. doi: 10.1371/journal.pone.0167770. eCollection 2017.

The clinical outcomes of chronic hepatitis C in South Korea: A prospective, multicenter cohort study.

Medicine (Baltimore). 2016 Aug;95(35):e4594. doi: 10.1097/MD.0000000000004594.

本文引用的文献

Elderly age is not a negative predictive factor for virological response to therapy with pegylated interferon-α and ribavirin in chronic hepatitis C virus patients.

Liver Int. 2014 Apr;34(4):551-7. doi: 10.1111/liv.12279. Epub 2013 Aug 29.

Faldaprevir and deleobuvir for HCV genotype 1 infection.

N Engl J Med. 2013 Aug 15;369(7):630-9. doi: 10.1056/NEJMoa1213557.

Causes of death and risk factors for mortality among HIV-infected patients receiving antiretroviral therapy in Korea.

J Korean Med Sci. 2013 Jul;28(7):990-7. doi: 10.3346/jkms.2013.28.7.990. Epub 2013 Jul 3.

Clinical and epidemiological features of hepatitis C virus infection in South Korea: a prospective, multicenter cohort study.

J Med Virol. 2013 Oct;85(10):1724-33. doi: 10.1002/jmv.23661. Epub 2013 Jun 28.

Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement.

Ann Intern Med. 2013 Sep 3;159(5):349-57. doi: 10.7326/0003-4819-159-5-201309030-00672.

Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C: a retrospective study.

Hepatology. 2013 Nov;58(5):1580-6. doi: 10.1002/hep.26519. Epub 2013 Sep 30.

Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation.

Liver Transpl. 2013 Jul;19(7):690-700. doi: 10.1002/lt.23669. Epub 2013 Jun 3.

Current and future therapies for hepatitis C virus infection.

N Engl J Med. 2013 May 16;368(20):1907-17. doi: 10.1056/NEJMra1213651.

Sofosbuvir for previously untreated chronic hepatitis C infection.

N Engl J Med. 2013 May 16;368(20):1878-87. doi: 10.1056/NEJMoa1214853. Epub 2013 Apr 23.

Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options.

N Engl J Med. 2013 May 16;368(20):1867-77. doi: 10.1056/NEJMoa1214854. Epub 2013 Apr 23.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验